Defiance Launched New Autism Impact Investment Fund
The fund tracks companies working in neurodiversity care, targeting those involved in research and clinical services.
Updated on Sept. 30, 2026 in Autism
Live Poll
Would you consider investing in funds that donate a portion of profits to social causes?
Defiance ETFs introduced the Defiance Autism Impact ETF (ticker: ASD) on June 1, 2026, to track the VettaFi Autism Impact Index. This investment vehicle captures companies providing services and therapies for the neurodiverse population.
Why it matters
The fund addresses significant gaps in the treatment landscape and responds to the rising financial demand for neurodiversity care services. Societal costs related to autism in the United States were projected to reach $461 billion by 2025.
The VettaFi Autism Impact Index tracks 38 global companies, with 15.84% year-to-date returns through August 2026. The index requires a minimum market capitalization of $250 million for constituent eligibility.
The players
Defiance ETFs
An investment management firm that develops thematic and specialized exchange-traded funds.
VettaFi
A data and analytics provider that creates financial indices for market research and investment tracking.
The details
The index selects companies based on clinical trial activity, specific product indications, and revenue exposure within the autism care sector. Holdings are distributed across global markets, with 58% in North America, 17% in Europe, and 13% in Asia. The ETF operates with a 0.79% gross expense ratio.
Timeline
Defiance ETFs launched the Defiance Autism Impact ETF on June 1, 2026.
The index returned 15.84% year-to-date as of August 2026.
Federal funding via the Autism CARES Act continues through 2029.
Health Landscape
This fund operates alongside the public funding landscape, such as the federal Autism CARES Act, which directs up to $350 million annually to the National Institutes of Health. It represents a private-sector effort to mirror the growing economic focus on neurodiversity clinical services.
While this fund highlights the growing industry for autism services, it does not change personal treatment protocols. You should continue to work with your physician to identify evidence-based therapies supported by current research.
The takeaway
Investment interest in autism care underscores the high societal cost of support, which can reach $3.2 million per individual over a lifetime. Families should prioritize consulting with qualified clinicians and local health agencies to navigate available care coverage mandates.
Further reading
For more on the current landscape of support, visit the Autism section.
Source note: This article includes information reported by ETF Trends.
Live Poll
Would you consider investing in funds that donate a portion of profits to social causes?
